TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ARDX

Ardelyx Inc

Healthcare · Biotechnology

3.50$ +2.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ARDX
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+434.7% +9.3% -24.0% +0.0% +74.8% -93.8% +102.6% +43.4% +33.4% +416.6% +138.6% +168.1% +22.1%
+1,369.3% +17.1% -96.0% -2.4% +548.6% -94.5% +28.8% -75.8% +589.7% +311.7% +332.2% +184.1% -15.7%
-76.1% +3,687.2% -24.0% -5.4% +47.8% -93.6% +118.6% +58.6% +22.5% +428.1% +122.0% +165.4% +28.9%
+175.9% -7.8% +54.0% +136.1% -19.8% -8.1% +3.3% -9.2% +40.1% -61.4% +1.0% +47.2% +30.9%
-8.2% +96.9% +85.7% +38.5% +24.0% +2.1% +2.3% +36.6% +118.1% +5.9% +75.5% +92.5% +30.4%
+123.7% +4.4% +61.0% +111.4% -12.6% -5.7% +3.1% +2.4% +66.4% -31.6% +52.0% +83.0% +30.4%
+62.0% -11.0% -11.7% +12.7% +74.9% +126.4% +41.3%
-85.2% -52.5% -143.3% +3,965.5% -99.7% +7,475.0% -99.3% +100.0% +100.0% +6,737.5% -51.4% +264.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?